BioCentury
ARTICLE | Clinical News

Prevenar regulatory update

March 9, 2009 7:00 AM UTC

Wyeth said Prevenar was approved in Russia to prevent pneumococcal disease in infants and young children. The heptavalent pneumococcal conjugate vaccine is marketed in over 90 countries. The company ...